These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 34871728)
1. The Utility of Handheld Cardiac and Lung Ultrasound in Predicting Outcomes of Hospitalised Patients With COVID-19. Dadon Z; Levi N; Orlev A; Belman D; Alpert EA; Glikson M; Gottlieb S; Butnaru A Can J Cardiol; 2022 Mar; 38(3):338-346. PubMed ID: 34871728 [TBL] [Abstract][Full Text] [Related]
3. Tablet-Based Limited Echocardiography to Reduce Sonographer Scan and Decontamination Time during the COVID-19 Pandemic. McMahon SR; De Francis G; Schwartz S; Duvall WL; Arora B; Silverman DI J Am Soc Echocardiogr; 2020 Jul; 33(7):895-899. PubMed ID: 32624089 [TBL] [Abstract][Full Text] [Related]
4. Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study. Szekely Y; Lichter Y; Taieb P; Banai A; Hochstadt A; Merdler I; Gal Oz A; Rothschild E; Baruch G; Peri Y; Arbel Y; Topilsky Y Circulation; 2020 Jul; 142(4):342-353. PubMed ID: 32469253 [TBL] [Abstract][Full Text] [Related]
5. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A; Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086 [TBL] [Abstract][Full Text] [Related]
6. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial. Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662 [TBL] [Abstract][Full Text] [Related]
7. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765 [TBL] [Abstract][Full Text] [Related]
8. The quality, safety, feasibility, and interpretive accuracy of echocardiographic and lung ultrasound assessment of COVID-19 patients using a hand-held ultrasound. Dadon Z; Levi N; Alpert EA; Orlev A; Belman D; Glikson M; Butnaru A; Gottlieb S Echocardiography; 2022 Jul; 39(7):886-894. PubMed ID: 35668047 [TBL] [Abstract][Full Text] [Related]
9. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial. Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638 [TBL] [Abstract][Full Text] [Related]
10. Feasibility of a 5G-Based Robot-Assisted Remote Ultrasound System for Cardiopulmonary Assessment of Patients With Coronavirus Disease 2019. Ye R; Zhou X; Shao F; Xiong L; Hong J; Huang H; Tong W; Wang J; Chen S; Cui A; Peng C; Zhao Y; Chen L Chest; 2021 Jan; 159(1):270-281. PubMed ID: 32653568 [TBL] [Abstract][Full Text] [Related]
11. Cardiac imaging phenotype in patients with coronavirus disease 2019 (COVID-19): results of the cocarde study. Lairez O; Blanchard V; Houard V; Vardon-Bounes F; Lemasle M; Cariou E; Lavie-Badie Y; Ruiz S; Cazalbou S; Delmas C; Georges B; Galinier M; Carrié D; Conil JM; Minville V Int J Cardiovasc Imaging; 2021 Feb; 37(2):449-457. PubMed ID: 32902783 [TBL] [Abstract][Full Text] [Related]
12. [Ultrasound in the management of the critically ill patient with SARS-CoV-2 infection (COVID-19): narrative review]. Fraile Gutiérrez V; Ayuela Azcárate JM; Pérez-Torres D; Zapata L; Rodríguez Yakushev A; Ochagavía A Med Intensiva (Engl Ed); 2020 Dec; 44(9):551-565. PubMed ID: 32527471 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of a new pocket echoscopic device for focused cardiac ultrasonography in an emergency setting. Biais M; Carrié C; Delaunay F; Morel N; Revel P; Janvier G Crit Care; 2012 May; 16(3):R82. PubMed ID: 22583539 [TBL] [Abstract][Full Text] [Related]
14. Echocardiography in suspected coronavirus infection: indications, limitations and impact on clinical management. Sheehan MM; Saijo Y; Popovic ZB; Faulx MD Open Heart; 2021 Aug; 8(2):. PubMed ID: 34376573 [TBL] [Abstract][Full Text] [Related]
15. High risk of malnutrition among hospitalised coronavirus disease 2019 (COVID-19) patients is associated with mortality and other clinical outcomes. Guðnadóttir SD; Gunnarsdóttir I; Hernandez UB; Ingadóttir ÁR Clin Nutr ESPEN; 2024 Jun; 61():1-7. PubMed ID: 38777420 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of biventricular function in patients with COVID-19 using speckle tracking echocardiography. Baycan OF; Barman HA; Atici A; Tatlisu A; Bolen F; Ergen P; Icten S; Gungor B; Caliskan M Int J Cardiovasc Imaging; 2021 Jan; 37(1):135-144. PubMed ID: 32803484 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II). Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356 [TBL] [Abstract][Full Text] [Related]
19. Elevated Cardiac Troponin I as a Mortality Predictor in Hospitalised COVID-19 Patients. Kubiliute I; Urboniene J; Majauskaite F; Bobkov E; Svetikas L; Jancoriene L Medicina (Kaunas); 2024 May; 60(6):. PubMed ID: 38929459 [No Abstract] [Full Text] [Related]
20. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]